Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
Hamza Bashir, HO Coordinator at Young Doctors Association (YDA), shared a post on LinkedIn:
“Post-thrombotic syndrome is one of those complications that is easy to overlook in the acute phase of DVT, but it can stay with patients for years: swelling, pain, heaviness, skin changes.
So we asked a simple question: does adding endovascular therapy to anticoagulation actually help prevent it?
Our answer is now published in JACC.
Accepted at TCT 2026 | Abstract in Journal of the American College of Cardiology
‘TCT-365: Endovascular Therapy Versus Anticoagulation Alone for Acute or Subacute Proximal Lower-Limb Deep Vein Thrombosis: An Updated Systematic
Review and Meta-Analysis’
Across 12 studies and 2,190 patients:
- Endovascular therapy lowered overall post-thrombotic syndrome by about 30% (RR 0.70)
- Moderate-to-severe PTS was roughly halved (RR 0.50)
- No significant difference in severe PTS, recurrent thromboembolism or mortality
The benefit is real, but high heterogeneity and variable follow-up mean patient selection still matters.
Grateful to all my co-authors for their hard work and collaboration.”
Title: TCT-365 Endovascular Therapy Versus Anticoagulation Alone for Acute or Subacute Proximal Lower-Limb Deep Vein Thrombosis: An Updated Systematic Review and Meta-Analysis
Authors: Ali Hassan, Sheraz Qasim, Rubiya Ali, Eshal Shabbir, Hamza Bashir Bashir, Tooba Rehman, Victory Okirie, Yasir Nadeem, Arooj Imran, Abdulrehman Shakeel shah, and Abdullah Sheikh

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms